Enterprise

Portugal signs nationwide AI physical therapy deal with Sword Health

The contract covering 10 million citizens could serve as a blueprint for U.S. Medicare expansion, according to the digital health company's CEO.

Omega Editorial· June 29, 2026· 3 min read

Portugal becomes first country to offer AI-powered physical therapy nationwide

Portugal has signed a contract with digital health company Sword Health to provide AI-supported physical therapy services to its entire population of 10 million people through the country's National Health Service.

Under the agreement finalized this month, Portuguese patients who receive a doctor's referral will gain unlimited access to Sword's virtual therapy platform. The system relies heavily on artificial intelligence to guide and supervise patient care remotely.

The arrangement represents the first time a national government has contracted AI-based physical therapy services at full population scale, according to reporting by STAT.

Why it matters

This deal tests whether AI-powered healthcare can work as a government-funded service for an entire nation — a question with direct implications for U.S. policymakers considering how Medicare and other federal programs should cover digital health tools. Sword's CEO indicated the Portugal model could inform future Medicare arrangements, suggesting the company views this as a proof point for broader government adoption of AI care platforms.

From Portuguese startup to U.S. digital health leader

Sword Health was founded in Portugal ten years ago and has since grown into one of the most prominent digital health companies focused on chronic condition management in the United States. The company's return to its home market with a nationwide contract marks a significant milestone in both its growth trajectory and the broader acceptance of AI-supervised care.

The timing comes as U.S. regulators and payers debate appropriate frameworks for supporting and reimbursing artificial intelligence-based medical services. Digital health companies have pushed for expanded coverage while critics raise questions about clinical oversight and patient safety in AI-guided care.

Testing AI care at national scale

The Portugal arrangement will provide a real-world laboratory for evaluating whether AI-powered physical therapy can deliver outcomes across diverse patient populations when deployed through a public health system. Unlike private insurance arrangements or employer-sponsored programs, the National Health Service contract means Sword's platform will need to serve patients across all age groups, socioeconomic backgrounds, and geographic regions.

Patients will access the service after receiving referrals from their physicians, maintaining a connection to traditional medical oversight while receiving AI-guided therapy remotely. The unlimited access model differs from many U.S. insurance plans that cap physical therapy visits or require ongoing authorization.

The company's CEO suggested the Portugal deal could serve as a template for how Medicare might structure coverage of AI-supported care services, though no specific U.S. government negotiations were disclosed.

Details of the contract's financial terms, duration, and performance metrics were not reported by STAT.

#ai healthcare#digital health#physical therapy#sword health#portugal#medicare

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise

Enterprise· 4 min read

Dr. Martens Rebuilt Customer Service From Scratch After Years of Decline

The footwear brand consolidated fragmented systems across regions onto Salesforce and AWS, reversing a three-year slide in customer satisfaction within months.

Via Automation Watch · Sep 24, 2026
Enterprise· 4 min read

AI Coding Tools Added $942M to Hospital Bills Without Care Changes

Blue Cross Blue Shield Association analysis finds hospitals using automation to classify more cases as complex, driving up costs with no documented increase in treatment intensity.

Via AI Watch · Sep 24, 2026
Enterprise· 4 min read

AI Clinical Trial Endpoints Fail at Scale Without Data Harmonization

Analysis of over one million patient screenings reveals that AI validation in single sites masks critical performance drift across multi-site deployments.

Via AI Watch · Sep 24, 2026